SARS-CoV-2-IN-14
CAS No. 22203-98-1
SARS-CoV-2-IN-14( —— )
Catalog No. M35435 CAS No. 22203-98-1
SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 86 | In Stock |
|
| 100MG | 127 | In Stock |
|
| 200MG | 184 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSARS-CoV-2-IN-14
-
NoteResearch use only, not for human use.
-
Brief DescriptionSARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide.
-
DescriptionSARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSARS-CoV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22203-98-1
-
Formula Weight282.12
-
Molecular FormulaC13H9Cl2NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (886.15 mM; Ultrasonic )
-
SMILESC(NC1=CC(Cl)=CC=C1)(=O)C2=C(O)C=CC(Cl)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Juang YP, et al. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2. Eur J Med Chem. 2022 May 5;235:114295.?
molnova catalog
related products
-
Bianthrone
Bianthrone is a natural product.
-
Fortunellin
Fortunellin is a natural product for research related to life sciences.
-
Sucrose
Sucrose is a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons.
Cart
sales@molnova.com